Supplements · Metabolic & Cardiometabolic
green tea decreases cardiovascular mortality
In plain terms: Does green tea protect your heart / help you live longer?
Part of: 🧪 Green tea
Maybe, maybe not. Big Asian studies link green tea drinkers to lower heart-disease deaths — but those people are healthier in general, and a genetics-based study that strips out that confounding found no actual causal effect. Promising association, not proven cause.
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
How the studies fall
What the evidence shows
Large Japanese/Asian cohorts consistently link higher green tea intake to lower cardiovascular and all-cause mortality — but this is OBSERVATIONAL (green-tea drinkers are healthier overall), the data barely generalize beyond Asia, and a Mendelian-randomization study (which is far less prone to confounding) found NO causal effect on heart disease or stroke. Association, not established causation.
The evidence (8)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Kuriyama S 2008 · J Nutr | observational | supports | moderate | Ohsaki follow-up review: green tea inversely associated with CVD mortality (HR 0.69, women), stronger for stroke. (Same Ohsaki cohort/group as Kuriyama 2006.) |
| Chung M et al. 2020 · Adv Nutr | meta-analysis | supports | moderate | Meta 39 cohorts: each cup/day tea ~4% lower CVD mortality; evidence low-to-moderate, larger effects in lower-quality studies. |
| Liang S et al. 2024 · Medicine (Baltimore) | observational | contradicts | moderate | Mendelian-randomization (Europeans + East Asians): NO causal association between genetically-predicted green tea and atrial fibrillation, heart failure, stroke, or coronary artery disease (all OR ~1.0) - undercuts the cohort signal. |
| Kim TL et al. 2024 · Epidemiol Health | meta-analysis | supports | moderate | Meta 38 cohorts: tea inversely associated with all-cause and CVD mortality; heterogeneity across tea types/regions. |
| Tang J et al. 2015 · Br J Nutr | meta-analysis | supports | moderate | Meta 18 prospective cohorts: highest vs lowest green tea - CVD mortality RR 0.67, all-cause RR 0.80; ~5%/cup lower CVD mortality. |
| Liu D et al. 2021 · Zhonghua Xin Xue Guan Bing Za Zhi | observational | supports | low | Dose-response meta (1.3M subjects): >=1 cup/d tea - CVD mortality RR 0.86; green-tea subgroup -15% (general+green tea). |
| Kuriyama S et al. 2006 · JAMA | observational | supports | high | Ohsaki cohort (n=40,530, Japan): >=5 cups/d vs low - all-cause mortality HR 0.84; CVD mortality HR 0.74 in women (weaker/null in men). |
| Igho-Osagie E et al. 2020 · J Nutr | meta-analysis | tested-null | moderate | Meta 14 RCTs (n=798): short-term green/black tea NO effect on BP or lipids - undercuts the proposed causal pathway. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.